Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | COVID-19 | Research

Incidence of symptomatic COVID-19 in close contacts of patients after discharge from hospital

Authors: Ayat Ahmadi, Amirhossein Poopak, Sina Nazemi, Negin Mohammadi, Bita Eslami, Monireh Sadat Seyyedsalehi, Leila Doshmangir, Seyyed Farshad Allameh, Kazem Zendehdel

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

There is a little evidence about the infectiousness of recovered COVID-19 patients. Considering that the circumstance of the isolation of the COVID-19 patients after-discharge is not always optimal, it is not very unlikely that viral transmission still occurs after hospital discharge. This study aims to investigate the incidence of symptomatic COVID-19 in close contacts of recovered patients after discharge from hospital.

Methods

Four hundred fifty discharged COVID-19 patients discharged from the largest public treatment center in Tehran, capital city of Iran, were followed up. Demographic and clinical data of participants were collected from medical records. Follow-up data were acquired via telephone call interviews with patients or their main caregivers at home.

Results

The study’s response rate was 93.77% (422 participated in the study). 60.90% patients were male and 39.10% were female (sex ratio = 1.55 male). The most prevalent comorbidities in these patients were hypertension (29.68%) and diabetes (24.80%). The mean of home isolation after discharge was 25.85. Forty-one (9.71%) patients had at least one new case in their close contacts, up to 3 weeks after they were discharged. There was a significant association between having at least a comorbidity with the odds of getting infected in close contacts [OR (CI) 2.22 (1.05–4.68)]. Density of inhabitant per room in a house’ and the quality of isolation had significant associations with observing new cases in the patients’ close contacts [high to moderate; OR (CI) 2.44 (1.06–5.61], [bad to good; OR (CI) 2.31 (1.17–4.59)], respectively.

Conclusion

After hospital discharge, COVID-19 transmission can still occur, when a large number of people lives together in a single house. Another explanation can be that the less precaution measures are taken by recovered patients’ cohabitants. Such conditions are also likely to happen when the recovered patient has other chronic diseases and requires additional care.
Literature
1.
go back to reference Zheng Z, Yao Z, Wu K, Zheng J. Patient follow-up after discharge after COVID-19 pneumonia: considerations for infectious control. J Med Virol. 2020;92(11):2412–9.CrossRef Zheng Z, Yao Z, Wu K, Zheng J. Patient follow-up after discharge after COVID-19 pneumonia: considerations for infectious control. J Med Virol. 2020;92(11):2412–9.CrossRef
2.
go back to reference Cheng H-Y, Jian S-W, Liu D-P, Ng T-C, Huang W-T, Lin H-H. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020;180(9):1156–63.CrossRef Cheng H-Y, Jian S-W, Liu D-P, Ng T-C, Huang W-T, Lin H-H. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020;180(9):1156–63.CrossRef
4.
go back to reference Yazdizadeh B, Majdzadeh R, Ahmadi A, Mesgarpour B. Health research system resilience: lesson learned from the COVID-19 crisis. Health Res Policy Syst. 2020;18(1):1–7.CrossRef Yazdizadeh B, Majdzadeh R, Ahmadi A, Mesgarpour B. Health research system resilience: lesson learned from the COVID-19 crisis. Health Res Policy Syst. 2020;18(1):1–7.CrossRef
5.
go back to reference World Health Organization. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. Geneva: World Health Organization; 2013. World Health Organization. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. Geneva: World Health Organization; 2013.
7.
go back to reference Foppiani A, Bertoli S, Battezzati A, Zuccotti G. Data to guide the application of the new WHO criteria for releasing COVID-19 patients from isolation. Pharmacol Res. 2020;160:105063.CrossRef Foppiani A, Bertoli S, Battezzati A, Zuccotti G. Data to guide the application of the new WHO criteria for releasing COVID-19 patients from isolation. Pharmacol Res. 2020;160:105063.CrossRef
8.
go back to reference Krupp KF, Madhivanan P, Perez-Velez CM. Should qualitative RT-PCR be used to determine release from isolation of COVID-19 patients? J Infect. 2020;81(3):452–82.CrossRef Krupp KF, Madhivanan P, Perez-Velez CM. Should qualitative RT-PCR be used to determine release from isolation of COVID-19 patients? J Infect. 2020;81(3):452–82.CrossRef
9.
go back to reference Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Pearson CA, Jombart T, Procter SR, Knight GM, Group CW. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18(1):1–22.CrossRef Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Pearson CA, Jombart T, Procter SR, Knight GM, Group CW. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18(1):1–22.CrossRef
10.
go back to reference Greysen SR, Auerbach AD, Mitchell MD, Goldstein JN, Weiss R, Esmaili A, Kuye I, Manjarrez E, Bann M, Schnipper JL. Discharge practices for COVID-19 patients: rapid review of published guidance and synthesis of documents and practices at 22 US Academic Medical Centers. J Gen Intern Med. 2021;36(6):1715–21.CrossRef Greysen SR, Auerbach AD, Mitchell MD, Goldstein JN, Weiss R, Esmaili A, Kuye I, Manjarrez E, Bann M, Schnipper JL. Discharge practices for COVID-19 patients: rapid review of published guidance and synthesis of documents and practices at 22 US Academic Medical Centers. J Gen Intern Med. 2021;36(6):1715–21.CrossRef
11.
go back to reference Cento V, Colagrossi L, Nava A, Lamberti A, Senatore S, Travi G, Rossotti R, Vecchi M, Casati O, Matarazzo E. Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients. J Infect. 2020;81(3):e90.CrossRef Cento V, Colagrossi L, Nava A, Lamberti A, Senatore S, Travi G, Rossotti R, Vecchi M, Casati O, Matarazzo E. Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients. J Infect. 2020;81(3):e90.CrossRef
12.
go back to reference Sze S, Pan D, Williams CM, Barker J, Minhas JS, Miller CJ, Tang JW, Squire IB, Pareek M. The need for improved discharge criteria for hospitalised patients with COVID-19—implications for patients in long-term care facilities. Age Ageing. 2021;50(1):16–20.CrossRef Sze S, Pan D, Williams CM, Barker J, Minhas JS, Miller CJ, Tang JW, Squire IB, Pareek M. The need for improved discharge criteria for hospitalised patients with COVID-19—implications for patients in long-term care facilities. Age Ageing. 2021;50(1):16–20.CrossRef
13.
go back to reference Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Berlin: Springer Science & Business Media; 2008. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Berlin: Springer Science & Business Media; 2008.
14.
go back to reference Rhee C, Kanjilal S, Baker M, Klompas M. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: when is it safe to discontinue isolation? Clin Infect Dis. 2021;72(8):1467–74.CrossRef Rhee C, Kanjilal S, Baker M, Klompas M. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: when is it safe to discontinue isolation? Clin Infect Dis. 2021;72(8):1467–74.CrossRef
15.
go back to reference Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568–76.CrossRef Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568–76.CrossRef
17.
go back to reference Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069–76.CrossRef Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069–76.CrossRef
18.
go back to reference Gesesew HA, Koye DN, Fetene DM, Woldegiorgis M, Kinfu Y, Geleto AB, Melaku YA, Mohammed H, Alene KA, Awoke MA. Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review. BMJ Open. 2021;11(2):e044618.CrossRef Gesesew HA, Koye DN, Fetene DM, Woldegiorgis M, Kinfu Y, Geleto AB, Melaku YA, Mohammed H, Alene KA, Awoke MA. Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review. BMJ Open. 2021;11(2):e044618.CrossRef
19.
go back to reference Hu S, Wang W, Wang Y, Litvinova M, Luo K, Ren L, Sun Q, Chen X, Zeng G, Li J. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat Commun. 2021;12(1):1–11.CrossRef Hu S, Wang W, Wang Y, Litvinova M, Luo K, Ren L, Sun Q, Chen X, Zeng G, Li J. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat Commun. 2021;12(1):1–11.CrossRef
21.
go back to reference Luo L, Liu D, Liao X-L, Wu X-B, Jing Q-L, Zheng J-Z, Liu F-H, Yang S-G, Bi B, Li Z-H. Modes of contact and risk of transmission in covid-19: a prospective cohort study 4950 close contact persons in Guangzhou of China. (3/29/2020). Avaolable at SSRN: https://doi.org/10.2139/ssrn.3566149. Luo L, Liu D, Liao X-L, Wu X-B, Jing Q-L, Zheng J-Z, Liu F-H, Yang S-G, Bi B, Li Z-H. Modes of contact and risk of transmission in covid-19: a prospective cohort study 4950 close contact persons in Guangzhou of China. (3/29/2020). Avaolable at SSRN: https://​doi.​org/​10.​2139/​ssrn.​3566149.
22.
go back to reference Cerami C, Rapp T, Lin F-C, Tompkins K, Basham C, Muller MS, Whittelsey M, Zhang H, Chhetri SB, Smith J. High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color. medRxiv. 2021. Cerami C, Rapp T, Lin F-C, Tompkins K, Basham C, Muller MS, Whittelsey M, Zhang H, Chhetri SB, Smith J. High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color. medRxiv. 2021.
23.
go back to reference Li W, Zhang B, Lu J, Liu S, Chang Z, Peng C, Liu X, Zhang P, Ling Y, Tao K. Characteristics of household transmission of COVID-19. Clin Infect Dis. 2020;71(8):1943–6.CrossRef Li W, Zhang B, Lu J, Liu S, Chang Z, Peng C, Liu X, Zhang P, Ling Y, Tao K. Characteristics of household transmission of COVID-19. Clin Infect Dis. 2020;71(8):1943–6.CrossRef
24.
go back to reference Ng OT, Marimuthu K, Koh V, Pang J, Linn KZ, Sun J, De Wang L, Chia WN, Tiu C, Chan M. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study. Lancet Infect Dis. 2021;21(3):333–43.CrossRef Ng OT, Marimuthu K, Koh V, Pang J, Linn KZ, Sun J, De Wang L, Chia WN, Tiu C, Chan M. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study. Lancet Infect Dis. 2021;21(3):333–43.CrossRef
25.
go back to reference Luo L LD, Liao X-I, et al. Modes of contact and risk of transmission in COVID-19 among close contacts. medRxiv. 2020. 2020.03.24.20042606. Luo L LD, Liao X-I, et al. Modes of contact and risk of transmission in COVID-19 among close contacts. medRxiv. 2020. 2020.03.24.20042606.
Metadata
Title
Incidence of symptomatic COVID-19 in close contacts of patients after discharge from hospital
Authors
Ayat Ahmadi
Amirhossein Poopak
Sina Nazemi
Negin Mohammadi
Bita Eslami
Monireh Sadat Seyyedsalehi
Leila Doshmangir
Seyyed Farshad Allameh
Kazem Zendehdel
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
COVID-19
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07300-x

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue